Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Veterinary Dermatology Market Outlook from 2024 to 2034

The veterinary dermatology market is projected to be valued at US$ 8.9 billion by 2024 and rise to US$ 22 billion by 2034. Veterinary dermatology is predicted to rise at a promising CAGR of 9.4% from 2024 to 2034.

Attributes Key Insights
Estimated Market Size in 2024 US$ 8.9 billion
Projected Market Value in 2034 US$ 22 billion
Value-based CAGR from 2024 to 2034 9.4%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Trends and Highlights

  • Integration of telemedicine and digital platforms for remote consultation and follow-up care in veterinary dermatology.
  • Increasing investment in research and development to discover innovative therapies and products for treating various pet skin conditions.
  • Growing demand for natural and organic pet skincare products, driven by consumer preference for safe and eco-friendly options.

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

During this period, the veterinary dermatology market witnessed a robust CAGR of 12.5%. Factors such as increasing awareness among pet owners about the significance of dermatological care for their pets, advancements in diagnostic techniques, and the introduction of novel treatment options contributed to this growth. The rising prevalence of skin diseases in pets fueled the demand for veterinary dermatology services and products.

The market is expected to continue its growth trajectory, albeit slightly slower, with a forecasted CAGR of 9.4% from 2024 to 2034. Factors such as sustained awareness initiatives, ongoing research and development efforts leading to the introduction of more advanced treatment modalities, and the expansion of veterinary dermatology facilities are anticipated to drive market growth during this period.

While the CAGR is lower compared to the historical trend, it signifies a steady and sustainable growth pattern in the veterinary dermatology market over the forecasted period.

Historical CAGR from 2019 to 2023 12.5%
Forecast CAGR from 2024 to 2034 9.4%
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Veterinary Dermatology Market Drivers

  • The growing number of pet owners worldwide is driving the demand for veterinary dermatology services and products as they become more aware of the importance of skin health in their pets.
  • Ongoing advancements in diagnostic techniques and treatment modalities, such as allergy testing and immunotherapy, are expanding the scope of veterinary dermatology, offering more effective solutions for various skin conditions in animals.
  • Heightened awareness among pet owners regarding the significance of preventive care and regular check-ups for their pets' skin health is boosting the demand for veterinary dermatology services.

Veterinary Dermatology Market Challenges

  • The cost associated with advanced dermatological treatments and specialized care can be prohibitive for some pet owners, limiting market penetration in certain segments.
  • The scarcity of qualified veterinary dermatologists in some regions poses a challenge in meeting the growing demand for specialized dermatological care for pets.
  • Skin diseases in animals can often be complex and challenging to diagnose accurately, leading to delays in treatment and management, which may affect market growth.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View of Adjacent Markets

Future Market Insights has compared three markets, namely the veterinary dermatology market, veterinary vaccines market and the veterinary biologics market are below. Growing awareness about zoonotic diseases and the importance of vaccination in preventing their transmission from animals to humans is propelling the demand for veterinary vaccines.

Advancements in biotechnology, particularly in the fields of genetic engineering and recombinant DNA technology, are driving the development of innovative veterinary biologics, fueling market growth.

Veterinary Dermatology Market:

Attributes Veterinary Dermatology Market
CAGR from 2024 to 2034 9.4%
Key Trend Increasing demand for natural and organic skincare products for pets.
Growth Factor Growing awareness among pet owners about the importance of preventive dermatological care for pets, driving the demand for specialized dermatological products and services.

Veterinary Vaccines Market:

Attributes Veterinary Vaccines Market
CAGR from 2023 to 2033 6.2%
Key Trend Development of novel vaccine technologies, such as DNA vaccines and vector vaccines.
Growth Factor The rising prevalence of infectious diseases in animals and the emphasis on disease prevention and control lead to the increased adoption of vaccines for disease management and eradication.

Veterinary Biologics Market:

Attributes Veterinary Biologics Market
CAGR from 2024 to 2034 6.3%
Key Trends Expansion of biopharmaceutical companies into veterinary medicine.
Growth Factor Increasing focus on personalized medicine and targeted therapies in veterinary care, driving the demand for biologics tailored to specific animal health needs and conditions.Top of Form

Country-wise Analysis

The provided table illustrates the top five countries in terms of revenue, with Japan holding a prominent position in the market. In Japan, the veterinary dermatology market stands out due to its advanced dermatological treatments and comprehensive care for companion animals.

With a strong emphasis on preventive medicine and the availability of high-quality veterinary care facilities, it addresses diverse skin conditions in pets, driving the market leadership in pet healthcare.

Countries Forecast CAGRs from 2024 to 2034
The United States 9.5%
The United Kingdom 10.1%
China 9.8%
Japan 10.7%
South Korea 10.2%

United States Holds Prominent Position in Pet Healthcare

Veterinary dermatology services and products are extensively utilized in the United States due to the high pet ownership rates and the culture of providing comprehensive healthcare to pets. The country boasts a network of veterinary clinics and hospitals offering specialized dermatological care for pets, ranging from diagnosis to treatment.

The increasing trend of pet humanization and the growing emphasis on pet wellness contributes to the significant utilization of veterinary dermatology in the United States.

Growing Pet Wellness Trend Drives the United Kingdom Market

In the United Kingdom, veterinary dermatology plays a crucial role in maintaining the health and well-being of companion animals. With a considerable population of pet owners who prioritize their pets' health, there is a strong demand for dermatological services and products. Veterinary dermatologists in the United Kingdom cater to a wide range of pet skin conditions, including allergies, infections, and autoimmune disorders.

The growing awareness about pet health and the availability of advanced diagnostic and therapeutic options drive the utilization of veterinary dermatology in the country.

Rising Pet Care Industry Surges the Market Growth in China

The utilization of veterinary dermatology in China is witnessing significant growth alongside the rising pet ownership rates and the increasing disposable income of pet owners. As pet owners become more aware of animal dermatological issues, a growing demand for specialized veterinary dermatology services and products is growing.

Veterinary dermatologists in China address various skin conditions in pets, including dermatitis, parasitic infestations, and hormonal imbalances. The expanding pet care industry and the introduction of advanced dermatological treatments contribute to the increasing utilization of veterinary dermatology in the country.

Japan Improvises Advanced Dermatological Treatments

Veterinary dermatology is widely utilized in Japan to address the diverse skin health needs of companion animals. With a large population of pet owners who prioritize their pets' well-being, there is a growing demand for specialized dermatological care.

Veterinary dermatologists in Japan employ advanced diagnostic techniques and treatment modalities to manage various skin conditions in pets, including allergies, infections, and neoplasms.

The availability of high-quality veterinary care facilities and the emphasis on preventive medicine drive the utilization of veterinary dermatology in the country.

Boost in Demand for Pet Services Raises the Market Growth in South Korea

In South Korea, veterinary dermatology is increasingly utilized to address the dermatological needs of companion animals. With a growing pet ownership culture and an increasing awareness of pet health issues, there is a rising demand for specialized dermatological services and products.

Veterinary dermatologists in South Korea provide comprehensive care for pets with various skin conditions, including allergic dermatitis, bacterial and fungal infections, and autoimmune diseases.

The growing pet care industry and the availability of advanced dermatological treatments contribute to the utilization of veterinary dermatology in the country.

Category-wise Insights

The below section shows the leading segment. Based on drug class, the antibacterial drugs segment is anticipated to rise at 9.2% CAGR by 2034. Based on the route of administration, the oral segment is anticipated to expand at 9% CAGR by 2034.

Rising concerns over antibiotic resistance in animals, necessitating the development and adoption of new and effective antibacterial drugs to combat bacterial infections in veterinary dermatology.

Convenience and ease of administration for both pet owners and veterinarians, driving the preference for oral medications in treating dermatological conditions in animals.Top of Form

Category CAGR from 2024 to 2034
Antibacterial Drugs 9.2%
Oral 9%

Antibacterial Drugs Segment to Hold a Significant Share in the Market

The segment focusing on antibacterial drugs is expected to experience a steady rise, with a projected CAGR of 9.2% by 2034.

This growth can be attributed to several factors, such as increasing incidences of bacterial infections in animals, the emergence of antibiotic-resistant strains, and ongoing research and development efforts to introduce new and more effective antibacterial treatments for veterinary use.

The growing emphasis on preventive healthcare measures for pets is also contributing to the expansion of this segment.

Oral Segment to Hold a Dominant Share in the Market

The oral route of administration segment is poised for significant growth, with an anticipated CAGR of 9% by 2034. This growth is driven by several factors, including the convenience and ease of administration associated with oral medications, making them a preferred choice for pet owners and veterinarians.

Advancements in pharmaceutical formulations and drug delivery technologies further enhance the efficacy and safety of oral veterinary medications, thus fueling the demand for oral treatments in the veterinary dermatology market.

Competitive Landscape

The competitive landscape of the veterinary dermatology market is characterized by the presence of several key players offering a wide range of products and services. These include veterinary pharmaceutical companies, specialty clinics, and diagnostic laboratories.

Competition is driven by product innovation, pricing strategies, and geographic presence. Partnerships and collaborations between industry players play a significant role in shaping competitive dynamics. Key focus areas include advanced diagnostic tools, novel treatment modalities, and personalized care solutions to meet the evolving needs of pet owners and veterinarians.

Some of the key developments

  • In September 2022, Zoetis finalized the acquisition of Jurox, enhancing its portfolio with key products and paving the way for global expansion.
  • In October 2022, Animal Dermatology Group, Inc. acquired the premier veterinary dermatology clinic, Animal Dermatology Referral Clinic, in the Dallas-Fort Worth area, consolidating its position in the market and expanding its service offerings.

Key Coverage of Veterinary Dermatology Market Report

  • Adjacent Study on Veterinary Dermatology Market, Veterinary Dermatology Drugs Market
  • Veterinary Dermatology Market Size, Current Insights, and Demographic Trends
  • Veterinary Dermatology Industry Growth Analysis
  • Global Veterinary Dermatology Market Opportunities
  • Strategies of Key Players in the Veterinary Dermatology Market

Report Scope

Attributes Details
Estimated Market Size in 2024 US$ 8.9 billion
Projected Market Valuation in 2034 US$ 22 billion
Value-based CAGR 2024 to 2034 9.4%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis Value in US$ billion
Key Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa
Key Market Segments Covered
  • Drug Class
  • Indication
  • Route of Administration
  • Animal Type
  • Distribution Channel
  • Region
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC countries
  • South Africa
  • Israel
Key Companies Profiled
  • Elanco Animal Health Incorporated
  • Vetoquinol S.A.
  • Ceva
  • Merck & Co., Inc.
  • Zoetis, Inc.
  • Virbac
  • Bimeda, Inc.
  • Vivaldis
  • Bioiberica S.A.U
  • Indian Immunologicals Ltd

Veterinary Dermatology Market - Key Segments

By Drug Class:

  • Antibacterial Drugs
  • Antifungal Drugs
  • Antiparasitic Drugs
  • Other Drug Classes

By Indication:

  • Parasitic Infections
  • Allergic Infections
  • Autoimmune Skin Diseases
  • Skin Cancer
  • Other Indications

By Route of Administration:

  • Injectable
  • Topical
  • Oral

By Animal Type:

  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Other Companion Animals
  • Livestock Animals
    • Bovine
    • Swine
    • Other Livestock Animals

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Frequently Asked Questions

What is the expected worth of the veterinary dermatology market in 2024?

As of 2024, the market for veterinary dermatology is expected to be valued at US$ 8.9 billion.

What is the anticipated market value for veterinary dermatology in 2034?

By 2034, the market value of veterinary dermatology is expected to reach US$ 22 billion.

What is the projected forecast CAGR for the veterinary dermatology market from 2024 to 2034?

From 2024 to 2034, the veterinary dermatology market is expected to flourish at a CAGR of 9.4%.

Based on drug class, which segment dominates the veterinary dermatology market?

The antibacterial drugs segment is registered to expand at 9.2% CAGR by 2034.

Which country is likely to dominate the veterinary dermatology market?

Japan is likely the top-performing market, with a CAGR of 10.7%.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drug Class

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Drug Class, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drug Class, 2024 to 2034

        5.3.1. Antibacterial Drugs

        5.3.2. Antifungal Drugs

        5.3.3. Antiparasitic Drugs

        5.3.4. Other Drug Classes

    5.4. Y-o-Y Growth Trend Analysis By Drug Class, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Drug Class, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2024 to 2034

        6.3.1. Parasitic Infections

        6.3.2. Allergic Infections

        6.3.3. Autoimmune Skin Diseases

        6.3.4. Skin Cancer

        6.3.5. Other Indications

    6.4. Y-o-Y Growth Trend Analysis By Indication, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Indication, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2024 to 2034

        7.3.1. Injectable

        7.3.2. Topical

        7.3.3. Oral

    7.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By Route of Administration, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Animal Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By Animal Type, 2019 to 2023

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Animal Type, 2024 to 2034

        8.3.1. Companion animal

            8.3.1.1. Dogs

            8.3.1.2. Cats

            8.3.1.3. Horses

            8.3.1.4. Other companion animals

        8.3.2. Livestock animal

            8.3.2.1. Bovine

            8.3.2.2. Swine

            8.3.2.3. Other livestock animals

    8.4. Y-o-Y Growth Trend Analysis By Animal Type, 2019 to 2023

    8.5. Absolute $ Opportunity Analysis By Animal Type, 2024 to 2034

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

    9.1. Introduction / Key Findings

    9.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2019 to 2023

    9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2024 to 2034

        9.3.1. Hospital pharmacies

        9.3.2. Retail pharmacies

        9.3.3. Online pharmacies

    9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023

    9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034

10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    10.1. Introduction

    10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Western Europe

        10.3.4. Eastern Europe

        10.3.5. South Asia and Pacific

        10.3.6. East Asia

        10.3.7. Middle East and Africa

    10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. USA

            11.2.1.2. Canada

        11.2.2. By Drug Class

        11.2.3. By Indication

        11.2.4. By Route of Administration

        11.2.5. By Animal Type

        11.2.6. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drug Class

        11.3.3. By Indication

        11.3.4. By Route of Administration

        11.3.5. By Animal Type

        11.3.6. By Distribution Channel

    11.4. Key Takeaways

12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Brazil

            12.2.1.2. Mexico

            12.2.1.3. Rest of Latin America

        12.2.2. By Drug Class

        12.2.3. By Indication

        12.2.4. By Route of Administration

        12.2.5. By Animal Type

        12.2.6. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Drug Class

        12.3.3. By Indication

        12.3.4. By Route of Administration

        12.3.5. By Animal Type

        12.3.6. By Distribution Channel

    12.4. Key Takeaways

13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. Germany

            13.2.1.2. UK

            13.2.1.3. France

            13.2.1.4. Spain

            13.2.1.5. Italy

            13.2.1.6. Rest of Western Europe

        13.2.2. By Drug Class

        13.2.3. By Indication

        13.2.4. By Route of Administration

        13.2.5. By Animal Type

        13.2.6. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Drug Class

        13.3.3. By Indication

        13.3.4. By Route of Administration

        13.3.5. By Animal Type

        13.3.6. By Distribution Channel

    13.4. Key Takeaways

14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. Poland

            14.2.1.2. Russia

            14.2.1.3. Czech Republic

            14.2.1.4. Romania

            14.2.1.5. Rest of Eastern Europe

        14.2.2. By Drug Class

        14.2.3. By Indication

        14.2.4. By Route of Administration

        14.2.5. By Animal Type

        14.2.6. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Drug Class

        14.3.3. By Indication

        14.3.4. By Route of Administration

        14.3.5. By Animal Type

        14.3.6. By Distribution Channel

    14.4. Key Takeaways

15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. India

            15.2.1.2. Bangladesh

            15.2.1.3. Australia

            15.2.1.4. New Zealand

            15.2.1.5. Rest of South Asia and Pacific

        15.2.2. By Drug Class

        15.2.3. By Indication

        15.2.4. By Route of Administration

        15.2.5. By Animal Type

        15.2.6. By Distribution Channel

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Drug Class

        15.3.3. By Indication

        15.3.4. By Route of Administration

        15.3.5. By Animal Type

        15.3.6. By Distribution Channel

    15.4. Key Takeaways

16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        16.2.1. By Country

            16.2.1.1. China

            16.2.1.2. Japan

            16.2.1.3. South Korea

        16.2.2. By Drug Class

        16.2.3. By Indication

        16.2.4. By Route of Administration

        16.2.5. By Animal Type

        16.2.6. By Distribution Channel

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Drug Class

        16.3.3. By Indication

        16.3.4. By Route of Administration

        16.3.5. By Animal Type

        16.3.6. By Distribution Channel

    16.4. Key Takeaways

17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        17.2.1. By Country

            17.2.1.1. GCC Countries

            17.2.1.2. South Africa

            17.2.1.3. Israel

            17.2.1.4. Rest of MEA

        17.2.2. By Drug Class

        17.2.3. By Indication

        17.2.4. By Route of Administration

        17.2.5. By Animal Type

        17.2.6. By Distribution Channel

    17.3. Market Attractiveness Analysis

        17.3.1. By Country

        17.3.2. By Drug Class

        17.3.3. By Indication

        17.3.4. By Route of Administration

        17.3.5. By Animal Type

        17.3.6. By Distribution Channel

    17.4. Key Takeaways

18. Key Countries Market Analysis

    18.1. USA

        18.1.1. Market Share Analysis, 2023

            18.1.1.1. By Drug Class

            18.1.1.2. By Indication

            18.1.1.3. By Route of Administration

            18.1.1.4. By Animal Type

            18.1.1.5. By Distribution Channel

    18.2. Canada

        18.2.1. Market Share Analysis, 2023

            18.2.1.1. By Drug Class

            18.2.1.2. By Indication

            18.2.1.3. By Route of Administration

            18.2.1.4. By Animal Type

            18.2.1.5. By Distribution Channel

    18.3. Brazil

        18.3.1. Market Share Analysis, 2023

            18.3.1.1. By Drug Class

            18.3.1.2. By Indication

            18.3.1.3. By Route of Administration

            18.3.1.4. By Animal Type

            18.3.1.5. By Distribution Channel

    18.4. Mexico

        18.4.1. Market Share Analysis, 2023

            18.4.1.1. By Drug Class

            18.4.1.2. By Indication

            18.4.1.3. By Route of Administration

            18.4.1.4. By Animal Type

            18.4.1.5. By Distribution Channel

    18.5. Germany

        18.5.1. Market Share Analysis, 2023

            18.5.1.1. By Drug Class

            18.5.1.2. By Indication

            18.5.1.3. By Route of Administration

            18.5.1.4. By Animal Type

            18.5.1.5. By Distribution Channel

    18.6. UK

        18.6.1. Market Share Analysis, 2023

            18.6.1.1. By Drug Class

            18.6.1.2. By Indication

            18.6.1.3. By Route of Administration

            18.6.1.4. By Animal Type

            18.6.1.5. By Distribution Channel

    18.7. France

        18.7.1. Market Share Analysis, 2023

            18.7.1.1. By Drug Class

            18.7.1.2. By Indication

            18.7.1.3. By Route of Administration

            18.7.1.4. By Animal Type

            18.7.1.5. By Distribution Channel

    18.8. Spain

        18.8.1. Market Share Analysis, 2023

            18.8.1.1. By Drug Class

            18.8.1.2. By Indication

            18.8.1.3. By Route of Administration

            18.8.1.4. By Animal Type

            18.8.1.5. By Distribution Channel

    18.9. Italy

        18.9.1. Market Share Analysis, 2023

            18.9.1.1. By Drug Class

            18.9.1.2. By Indication

            18.9.1.3. By Route of Administration

            18.9.1.4. By Animal Type

            18.9.1.5. By Distribution Channel

    18.10. Poland

        18.10.1. Market Share Analysis, 2023

            18.10.1.1. By Drug Class

            18.10.1.2. By Indication

            18.10.1.3. By Route of Administration

            18.10.1.4. By Animal Type

            18.10.1.5. By Distribution Channel

    18.11. Russia

        18.11.1. Market Share Analysis, 2023

            18.11.1.1. By Drug Class

            18.11.1.2. By Indication

            18.11.1.3. By Route of Administration

            18.11.1.4. By Animal Type

            18.11.1.5. By Distribution Channel

    18.12. Czech Republic

        18.12.1. Market Share Analysis, 2023

            18.12.1.1. By Drug Class

            18.12.1.2. By Indication

            18.12.1.3. By Route of Administration

            18.12.1.4. By Animal Type

            18.12.1.5. By Distribution Channel

    18.13. Romania

        18.13.1. Market Share Analysis, 2023

            18.13.1.1. By Drug Class

            18.13.1.2. By Indication

            18.13.1.3. By Route of Administration

            18.13.1.4. By Animal Type

            18.13.1.5. By Distribution Channel

    18.14. India

        18.14.1. Market Share Analysis, 2023

            18.14.1.1. By Drug Class

            18.14.1.2. By Indication

            18.14.1.3. By Route of Administration

            18.14.1.4. By Animal Type

            18.14.1.5. By Distribution Channel

    18.15. Bangladesh

        18.15.1. Market Share Analysis, 2023

            18.15.1.1. By Drug Class

            18.15.1.2. By Indication

            18.15.1.3. By Route of Administration

            18.15.1.4. By Animal Type

            18.15.1.5. By Distribution Channel

    18.16. Australia

        18.16.1. Market Share Analysis, 2023

            18.16.1.1. By Drug Class

            18.16.1.2. By Indication

            18.16.1.3. By Route of Administration

            18.16.1.4. By Animal Type

            18.16.1.5. By Distribution Channel

    18.17. New Zealand

        18.17.1. Market Share Analysis, 2023

            18.17.1.1. By Drug Class

            18.17.1.2. By Indication

            18.17.1.3. By Route of Administration

            18.17.1.4. By Animal Type

            18.17.1.5. By Distribution Channel

    18.18. China

        18.18.1. Market Share Analysis, 2023

            18.18.1.1. By Drug Class

            18.18.1.2. By Indication

            18.18.1.3. By Route of Administration

            18.18.1.4. By Animal Type

            18.18.1.5. By Distribution Channel

    18.19. Japan

        18.19.1. Market Share Analysis, 2023

            18.19.1.1. By Drug Class

            18.19.1.2. By Indication

            18.19.1.3. By Route of Administration

            18.19.1.4. By Animal Type

            18.19.1.5. By Distribution Channel

    18.20. South Korea

        18.20.1. Market Share Analysis, 2023

            18.20.1.1. By Drug Class

            18.20.1.2. By Indication

            18.20.1.3. By Route of Administration

            18.20.1.4. By Animal Type

            18.20.1.5. By Distribution Channel

    18.21. GCC Countries

        18.21.1. Market Share Analysis, 2023

            18.21.1.1. By Drug Class

            18.21.1.2. By Indication

            18.21.1.3. By Route of Administration

            18.21.1.4. By Animal Type

            18.21.1.5. By Distribution Channel

    18.22. South Africa

        18.22.1. Market Share Analysis, 2023

            18.22.1.1. By Drug Class

            18.22.1.2. By Indication

            18.22.1.3. By Route of Administration

            18.22.1.4. By Animal Type

            18.22.1.5. By Distribution Channel

    18.23. Israel

        18.23.1. Market Share Analysis, 2023

            18.23.1.1. By Drug Class

            18.23.1.2. By Indication

            18.23.1.3. By Route of Administration

            18.23.1.4. By Animal Type

            18.23.1.5. By Distribution Channel

19. Market Structure Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Market Share Analysis of Top Players

        19.3.1. By Regional

        19.3.2. By Drug Class

        19.3.3. By Indication

        19.3.4. By Route of Administration

        19.3.5. By Animal Type

        19.3.6. By Distribution Channel

20. Competition Analysis

    20.1. Competition Deep Dive

        20.1.1. Elanco Animal Health Incorporated

            20.1.1.1. Overview

            20.1.1.2. Product Portfolio

            20.1.1.3. Profitability by Market Segments

            20.1.1.4. Sales Footprint

            20.1.1.5. Strategy Overview

                20.1.1.5.1. Marketing Strategy

        20.1.2. Vetoquinol S.A.

            20.1.2.1. Overview

            20.1.2.2. Product Portfolio

            20.1.2.3. Profitability by Market Segments

            20.1.2.4. Sales Footprint

            20.1.2.5. Strategy Overview

                20.1.2.5.1. Marketing Strategy

        20.1.3. Ceva

            20.1.3.1. Overview

            20.1.3.2. Product Portfolio

            20.1.3.3. Profitability by Market Segments

            20.1.3.4. Sales Footprint

            20.1.3.5. Strategy Overview

                20.1.3.5.1. Marketing Strategy

        20.1.4. Merck & Co., Inc.

            20.1.4.1. Overview

            20.1.4.2. Product Portfolio

            20.1.4.3. Profitability by Market Segments

            20.1.4.4. Sales Footprint

            20.1.4.5. Strategy Overview

                20.1.4.5.1. Marketing Strategy

        20.1.5. Zoetis, Inc.

            20.1.5.1. Overview

            20.1.5.2. Product Portfolio

            20.1.5.3. Profitability by Market Segments

            20.1.5.4. Sales Footprint

            20.1.5.5. Strategy Overview

                20.1.5.5.1. Marketing Strategy

        20.1.6. Virbac

            20.1.6.1. Overview

            20.1.6.2. Product Portfolio

            20.1.6.3. Profitability by Market Segments

            20.1.6.4. Sales Footprint

            20.1.6.5. Strategy Overview

                20.1.6.5.1. Marketing Strategy

        20.1.7. Bimeda, Inc.

            20.1.7.1. Overview

            20.1.7.2. Product Portfolio

            20.1.7.3. Profitability by Market Segments

            20.1.7.4. Sales Footprint

            20.1.7.5. Strategy Overview

                20.1.7.5.1. Marketing Strategy

        20.1.8. Vivaldis

            20.1.8.1. Overview

            20.1.8.2. Product Portfolio

            20.1.8.3. Profitability by Market Segments

            20.1.8.4. Sales Footprint

            20.1.8.5. Strategy Overview

                20.1.8.5.1. Marketing Strategy

        20.1.9. Bioiberica S.A.U

            20.1.9.1. Overview

            20.1.9.2. Product Portfolio

            20.1.9.3. Profitability by Market Segments

            20.1.9.4. Sales Footprint

            20.1.9.5. Strategy Overview

                20.1.9.5.1. Marketing Strategy

        20.1.10. Indian Immunologicals Ltd

            20.1.10.1. Overview

            20.1.10.2. Product Portfolio

            20.1.10.3. Profitability by Market Segments

            20.1.10.4. Sales Footprint

            20.1.10.5. Strategy Overview

                20.1.10.5.1. Marketing Strategy

21. Assumptions & Acronyms Used

22. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Indication, 2019 to 2034

Table 4: Global Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 5: Global Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 6: Global Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 7: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 8: North America Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 9: North America Market Value (US$ Million) Forecast by Indication, 2019 to 2034

Table 10: North America Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 11: North America Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 12: North America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Latin America Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 15: Latin America Market Value (US$ Million) Forecast by Indication, 2019 to 2034

Table 16: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 17: Latin America Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 18: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 20: Western Europe Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 21: Western Europe Market Value (US$ Million) Forecast by Indication, 2019 to 2034

Table 22: Western Europe Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 23: Western Europe Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 24: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 26: Eastern Europe Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 27: Eastern Europe Market Value (US$ Million) Forecast by Indication, 2019 to 2034

Table 28: Eastern Europe Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 29: Eastern Europe Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 30: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 32: South Asia and Pacific Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Indication, 2019 to 2034

Table 34: South Asia and Pacific Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 36: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 38: East Asia Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 39: East Asia Market Value (US$ Million) Forecast by Indication, 2019 to 2034

Table 40: East Asia Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 41: East Asia Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 42: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 44: Middle East and Africa Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Indication, 2019 to 2034

Table 46: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 47: Middle East and Africa Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 48: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Indication, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 4: Global Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 5: Global Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 6: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 7: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 10: Global Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 11: Global Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 12: Global Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 13: Global Market Value (US$ Million) Analysis by Indication, 2019 to 2034

Figure 14: Global Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034

Figure 15: Global Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034

Figure 16: Global Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 17: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 18: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 19: Global Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 20: Global Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 21: Global Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 22: Global Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 23: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 24: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 25: Global Market Attractiveness by Drug Class, 2024 to 2034

Figure 26: Global Market Attractiveness by Indication, 2024 to 2034

Figure 27: Global Market Attractiveness by Route of Administration, 2024 to 2034

Figure 28: Global Market Attractiveness by Animal Type, 2024 to 2034

Figure 29: Global Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 30: Global Market Attractiveness by Region, 2024 to 2034

Figure 31: North America Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 32: North America Market Value (US$ Million) by Indication, 2024 to 2034

Figure 33: North America Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 34: North America Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 35: North America Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 36: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 37: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 40: North America Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 41: North America Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 42: North America Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 43: North America Market Value (US$ Million) Analysis by Indication, 2019 to 2034

Figure 44: North America Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034

Figure 45: North America Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034

Figure 46: North America Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 47: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 48: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 49: North America Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 50: North America Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 51: North America Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 52: North America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 53: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 54: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 55: North America Market Attractiveness by Drug Class, 2024 to 2034

Figure 56: North America Market Attractiveness by Indication, 2024 to 2034

Figure 57: North America Market Attractiveness by Route of Administration, 2024 to 2034

Figure 58: North America Market Attractiveness by Animal Type, 2024 to 2034

Figure 59: North America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 60: North America Market Attractiveness by Country, 2024 to 2034

Figure 61: Latin America Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 62: Latin America Market Value (US$ Million) by Indication, 2024 to 2034

Figure 63: Latin America Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 64: Latin America Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 65: Latin America Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 66: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 67: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 70: Latin America Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 71: Latin America Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 72: Latin America Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 73: Latin America Market Value (US$ Million) Analysis by Indication, 2019 to 2034

Figure 74: Latin America Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034

Figure 75: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034

Figure 76: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 77: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 78: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 79: Latin America Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 80: Latin America Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 82: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 83: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 84: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 85: Latin America Market Attractiveness by Drug Class, 2024 to 2034

Figure 86: Latin America Market Attractiveness by Indication, 2024 to 2034

Figure 87: Latin America Market Attractiveness by Route of Administration, 2024 to 2034

Figure 88: Latin America Market Attractiveness by Animal Type, 2024 to 2034

Figure 89: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 90: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 91: Western Europe Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 92: Western Europe Market Value (US$ Million) by Indication, 2024 to 2034

Figure 93: Western Europe Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 94: Western Europe Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 95: Western Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 96: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 97: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 98: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 99: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 100: Western Europe Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 101: Western Europe Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 102: Western Europe Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 103: Western Europe Market Value (US$ Million) Analysis by Indication, 2019 to 2034

Figure 104: Western Europe Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034

Figure 105: Western Europe Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034

Figure 106: Western Europe Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 107: Western Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 108: Western Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 109: Western Europe Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 110: Western Europe Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 111: Western Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 112: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 113: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 114: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 115: Western Europe Market Attractiveness by Drug Class, 2024 to 2034

Figure 116: Western Europe Market Attractiveness by Indication, 2024 to 2034

Figure 117: Western Europe Market Attractiveness by Route of Administration, 2024 to 2034

Figure 118: Western Europe Market Attractiveness by Animal Type, 2024 to 2034

Figure 119: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 120: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 121: Eastern Europe Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 122: Eastern Europe Market Value (US$ Million) by Indication, 2024 to 2034

Figure 123: Eastern Europe Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 124: Eastern Europe Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 125: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 126: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 127: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 128: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 129: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 130: Eastern Europe Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 131: Eastern Europe Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 132: Eastern Europe Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 133: Eastern Europe Market Value (US$ Million) Analysis by Indication, 2019 to 2034

Figure 134: Eastern Europe Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034

Figure 135: Eastern Europe Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034

Figure 136: Eastern Europe Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 137: Eastern Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 138: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 139: Eastern Europe Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 140: Eastern Europe Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 141: Eastern Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 142: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 143: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 144: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 145: Eastern Europe Market Attractiveness by Drug Class, 2024 to 2034

Figure 146: Eastern Europe Market Attractiveness by Indication, 2024 to 2034

Figure 147: Eastern Europe Market Attractiveness by Route of Administration, 2024 to 2034

Figure 148: Eastern Europe Market Attractiveness by Animal Type, 2024 to 2034

Figure 149: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 150: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 151: South Asia and Pacific Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 152: South Asia and Pacific Market Value (US$ Million) by Indication, 2024 to 2034

Figure 153: South Asia and Pacific Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 154: South Asia and Pacific Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 155: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 156: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 157: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 158: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 159: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 160: South Asia and Pacific Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 161: South Asia and Pacific Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 162: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 163: South Asia and Pacific Market Value (US$ Million) Analysis by Indication, 2019 to 2034

Figure 164: South Asia and Pacific Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034

Figure 165: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034

Figure 166: South Asia and Pacific Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 167: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 168: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 169: South Asia and Pacific Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 170: South Asia and Pacific Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 171: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 172: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 173: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 174: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 175: South Asia and Pacific Market Attractiveness by Drug Class, 2024 to 2034

Figure 176: South Asia and Pacific Market Attractiveness by Indication, 2024 to 2034

Figure 177: South Asia and Pacific Market Attractiveness by Route of Administration, 2024 to 2034

Figure 178: South Asia and Pacific Market Attractiveness by Animal Type, 2024 to 2034

Figure 179: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 180: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 181: East Asia Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 182: East Asia Market Value (US$ Million) by Indication, 2024 to 2034

Figure 183: East Asia Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 184: East Asia Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 185: East Asia Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 186: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 187: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 188: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 189: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 190: East Asia Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 191: East Asia Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 192: East Asia Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 193: East Asia Market Value (US$ Million) Analysis by Indication, 2019 to 2034

Figure 194: East Asia Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034

Figure 195: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034

Figure 196: East Asia Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 197: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 198: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 199: East Asia Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 200: East Asia Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 201: East Asia Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 202: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 203: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 204: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 205: East Asia Market Attractiveness by Drug Class, 2024 to 2034

Figure 206: East Asia Market Attractiveness by Indication, 2024 to 2034

Figure 207: East Asia Market Attractiveness by Route of Administration, 2024 to 2034

Figure 208: East Asia Market Attractiveness by Animal Type, 2024 to 2034

Figure 209: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 210: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 211: Middle East and Africa Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 212: Middle East and Africa Market Value (US$ Million) by Indication, 2024 to 2034

Figure 213: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 214: Middle East and Africa Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 215: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 216: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 217: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 218: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 219: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 220: Middle East and Africa Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 221: Middle East and Africa Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 222: Middle East and Africa Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 223: Middle East and Africa Market Value (US$ Million) Analysis by Indication, 2019 to 2034

Figure 224: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034

Figure 225: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034

Figure 226: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 227: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 228: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 229: Middle East and Africa Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 230: Middle East and Africa Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 231: Middle East and Africa Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 232: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 233: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 234: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 235: Middle East and Africa Market Attractiveness by Drug Class, 2024 to 2034

Figure 236: Middle East and Africa Market Attractiveness by Indication, 2024 to 2034

Figure 237: Middle East and Africa Market Attractiveness by Route of Administration, 2024 to 2034

Figure 238: Middle East and Africa Market Attractiveness by Animal Type, 2024 to 2034

Figure 239: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 240: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

Recommendations

Healthcare

Veterinary Biologics Market

Published : January 2024

Healthcare

Veterinary Wound Debridement Market

Published : July 2023

Healthcare

Veterinary Pain Management Drugs Market

Published : January 2023

Healthcare

Veterinary Vaccines Market

Published : January 2023

Explore Healthcare Insights

View Reports

Veterinary Dermatology Market